Report cover image

Retinal Biologics Market – By Drug Class (VEGF-A Antagonist, TNF-a Inhibitor) Indication (Macular Degeneration, Diabetic Retinopathy, Uveitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Global Forecast (2024 – 2032)

Publisher Global Market Insights
Published Apr 19, 2024
Length 114 Pages
SKU # GMI19004499

Description

Table of Contents

114 Pages
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of retinal diseases 3.2.1.2 Rising research & development activities related to retinal biologics 3.2.1.3 Advancements in biologic therapies 3.2.2 Industry pitfalls & challenges 3.2.2.1 Stringent regulatory requirements 3.2.2.2 Risk of potential adverse effects 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Pipeline analysis 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 VEGF-A antagonist 5.3 TNF-a inhibitor Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Macular degeneration 6.3 Diabetic retinopathy 6.4 Uveitis 6.5 Other indications Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Hospital pharmacies 7.3 Retail pharmacies 7.4 Online pharmacies Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 France 8.3.4 Spain 8.3.5 Italy 8.3.6 Netherlands 8.3.7 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Australia 8.4.5 South Korea 8.4.6 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Mexico 8.5.3 Rest of Latin America 8.6 Middle East and Africa 8.6.1 South Africa 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Rest of Middle East and Africa Chapter 9 Company Profiles 9.1 AbbVie Inc. 9.2 Amgen Inc. 9.3 Janssen Pharmaceuticals (Johnson & Johnson) 9.4 F-Hoffman La Roche Ltd. 9.5 Oxurion NV 9.6 Novartis AG 9.7 MeiraGTx Limited 9.8 Regeneron Pharmaceuticals Inc. 9.9 OncoGene Pharmaceuticals 9.10 SemaThera Inc.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us